Answers are grounded in this paper and cite their sources.
Paraoxonase-1 (PON1) and Myeloperoxidase (MPO), which are both components of the innate immune system and known markers of oxidative stress, have been observed to play a role in the pathogenesis of various diseases. An elevated MPO/PON1 ratio has been proposed as a surrogate marker of dysfunctional high-density lipoprotein, which is characterised by impaired antioxidant and anti-inflammatory properties and has been linked to a variety of inflammatory and chronic disorders. In this study, our primary objective was to evaluate the relationship between TOA and oxidative stress profile through comparative analysis of MPO, PON1, and their ratio in TOA patients versus healthy controls. Secondarily, we conducted an exploratory analysis to assess whether these markers could provide additional discriminatory value in patients with TOA. This study was designed as a cross-sectional comparative study. PON1 activity, MPO concentration, and the MPO/PON1 ratio were compared between 34 patients diagnosed with tubo-ovarian abscess (TOA) and 46 healthy controls. The discriminatory capacity of these oxidative markers in distinguishing patients with TOA from healthy controls was evaluated using receiver operating characteristic (ROC) curve analysis. Additionally, demographic characteristics, laboratory and clinical findings, and treatment modalities of the patients were examined. In the TOA group, serum MPO concentrations were significantly higher than in controls (median 168.40 vs. 51.93 ng/mL; p < 0.001). In contrast, PON1 activity was significantly lower in TOA patients compared with controls (median 150.80 vs. 235.67 U/L; p < 0.001). The MPO/PON1 ratio was significantly elevated in the TOA group relative to controls (median 1.059 vs. 0.228; p < 0.001). ROC curve analysis revealed that all three biomarkers (MPO, PON1, and the MPO/PON1 ratio) exhibited statistically significant discriminatory capacity (all p < 0.001). These findings suggest that TOA is associated with a pro-oxidative shift characterised by increased neutrophil-derived MPO concentrations, decreased antioxidant PON1 activity, and an elevated MPO/PON1 ratio, which may serve as a surrogate marker of HDL dysfunction. This altered oxidative stress profile in TOA represents the principal finding of the present study. Although these biomarkers demonstrated discriminatory capacity between patients with TOA and healthy controls, their clinical utility in distinguishing TOA from other causes of pelvic inflammation remains to be established through further validation in larger, prospective studies involving appropriate clinical comparison groups. ClinicalTrials.gov Identifier: NCT05443282. First submitted on July 24, 2026.
No takes yet. Share an insight, caveat, or question.
Ceyhan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: